192 related articles for article (PubMed ID: 22212957)
1. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
Fragliasso V; Chiodo Y; Ferrari-Amorotti G; Soliera AR; Manzotti G; Cattelani S; Candini O; Grisendi G; Vergalli J; Mariani SA; Guerzoni C; Calabretta B
J Cell Biochem; 2012 May; 113(5):1704-13. PubMed ID: 22212957
[TBL] [Abstract][Full Text] [Related]
2. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.
Radomska HS; Bassères DS; Zheng R; Zhang P; Dayaram T; Yamamoto Y; Sternberg DW; Lokker N; Giese NA; Bohlander SK; Schnittger S; Delmotte MH; Davis RJ; Small D; Hiddemann W; Gilliland DG; Tenen DG
J Exp Med; 2006 Feb; 203(2):371-81. PubMed ID: 16446383
[TBL] [Abstract][Full Text] [Related]
3. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
4. The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain.
Ferrari-Amorotti G; Mariani SA; Novi C; Cattelani S; Pecorari L; Corradini F; Soliera AR; Manzotti G; Fragliasso V; Zhang Y; Martinez RV; Lam EW; Guerzoni C; Calabretta B
J Biol Chem; 2010 Oct; 285(40):30837-50. PubMed ID: 20659895
[TBL] [Abstract][Full Text] [Related]
5. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
Shimokawa T; Nunomura S; Fujisawa D; Ra C
Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
8. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of C/EBPalpha inhibits granulopoiesis.
Ross SE; Radomska HS; Wu B; Zhang P; Winnay JN; Bajnok L; Wright WS; Schaufele F; Tenen DG; MacDougald OA
Mol Cell Biol; 2004 Jan; 24(2):675-86. PubMed ID: 14701740
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858
[TBL] [Abstract][Full Text] [Related]
11. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.
Lidonnici MR; Audia A; Soliera AR; Prisco M; Ferrari-Amorotti G; Waldron T; Donato N; Zhang Y; Martinez RV; Holyoake TL; Calabretta B
Cancer Res; 2010 Oct; 70(20):7949-59. PubMed ID: 20924107
[TBL] [Abstract][Full Text] [Related]
12. Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248.
Behre G; Singh SM; Liu H; Bortolin LT; Christopeit M; Radomska HS; Rangatia J; Hiddemann W; Friedman AD; Tenen DG
J Biol Chem; 2002 Jul; 277(29):26293-9. PubMed ID: 11978795
[TBL] [Abstract][Full Text] [Related]
13. Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.
Radomska HS; Alberich-Jordà M; Will B; Gonzalez D; Delwel R; Tenen DG
J Clin Invest; 2012 Aug; 122(8):2955-66. PubMed ID: 22797303
[TBL] [Abstract][Full Text] [Related]
14. Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes.
Zaragoza K; Bégay V; Schuetz A; Heinemann U; Leutz A
Mol Cell Biol; 2010 May; 30(9):2293-304. PubMed ID: 20176812
[TBL] [Abstract][Full Text] [Related]
15. E3 ligase SCF
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
[TBL] [Abstract][Full Text] [Related]
16. Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia.
Singh AK; Upadhyay V; Sethi A; Chowdhury S; Mishra S; Verma SP; Bhatt MLB; Trivedi AK
Biochem J; 2024 May; 481(10):653-666. PubMed ID: 38666590
[TBL] [Abstract][Full Text] [Related]
17. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
Cleaves R; Wang QF; Friedman AD
Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
[TBL] [Abstract][Full Text] [Related]
18. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.
Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R
Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649
[TBL] [Abstract][Full Text] [Related]
19. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of C/EBPα inhibits its granulopoietic function.
Bararia D; Kwok HS; Welner RS; Numata A; Sárosi MB; Yang H; Wee S; Tschuri S; Ray D; Weigert O; Levantini E; Ebralidze AK; Gunaratne J; Tenen DG
Nat Commun; 2016 Mar; 7():10968. PubMed ID: 27005833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
